ImmuneXcite Garners $8,600,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f496685-d9ba-4584-927d-4519115b0559 - Date
12/11/2015 - Company Name
ImmuneXcite - Mailing Address
3 Forbes Road Lexington, MA 02421 USA - Company Description
ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets. - Website
http://www.immunexcite.com - Transaction Type
Venture Equity - Transaction Amount
$8,600,000 - Transaction Round
Series A - Proceeds Purposes
ImmuneXcite plans to use the funding to complete studies that will enable selection of a lead program to advance into clinical trials. - M&A Terms
- Venture Investor
Cormorant Asset Management - Venture Investor
Sanofi-Genzyme BioVentures - Venture Investor
Partners Innovation Fund
